Amélie Bonnefond1,2,3, Philippe Froguel4,5,6. 1. Inserm UMR1283, CNRS UMR8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, Lille, France. amelie.bonnefond@inserm.fr. 2. Université de Lille, CHU de Lille, Lille, France. amelie.bonnefond@inserm.fr. 3. Department of Metabolism, Imperial College London, London, UK. amelie.bonnefond@inserm.fr. 4. Inserm UMR1283, CNRS UMR8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, Lille, France. p.froguel@imperial.ac.uk. 5. Université de Lille, CHU de Lille, Lille, France. p.froguel@imperial.ac.uk. 6. Department of Metabolism, Imperial College London, London, UK. p.froguel@imperial.ac.uk.
Authors: Robert Wagner; Martin Heni; Adam G Tabák; Jürgen Machann; Fritz Schick; Elko Randrianarisoa; Martin Hrabě de Angelis; Andreas L Birkenfeld; Norbert Stefan; Andreas Peter; Hans-Ulrich Häring; Andreas Fritsche Journal: Nat Med Date: 2021-01-04 Impact factor: 53.440
Authors: Diego Yacamán Méndez; Minhao Zhou; Ylva Trolle Lagerros; Donaji V Gómez Velasco; Per Tynelius; Hrafnhildur Gudjonsdottir; Antonio Ponce de Leon; Katarina Eeg-Olofsson; Claes-Göran Östenson; Boel Brynedal; Carlos A Aguilar Salinas; David Ebbevi; Anton Lager Journal: BMC Med Date: 2022-10-18 Impact factor: 11.150